MENU
+Compare
GKOS
Stock ticker: NYSE
AS OF
Nov 21 closing price
Price
$99.62
Change
+$4.42 (+4.64%)
Capitalization
5.72B

GKOS Glaukos Corp Forecast, Technical & Fundamental Analysis

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases... Show more

GKOS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for GKOS with price predictions
Nov 21, 2025

Momentum Indicator for GKOS turns positive, indicating new upward trend

GKOS saw its Momentum Indicator move above the 0 level on October 30, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 96 similar instances where the indicator turned positive. In of the 96 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for GKOS just turned positive on October 30, 2025. Looking at past instances where GKOS's MACD turned positive, the stock continued to rise in of 55 cases over the following month. The odds of a continued upward trend are .

GKOS moved above its 50-day moving average on November 10, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for GKOS crossed bullishly above the 50-day moving average on November 11, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GKOS advanced for three days, in of 320 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GKOS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

GKOS broke above its upper Bollinger Band on November 19, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GKOS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GKOS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.435) is normal, around the industry mean (62.988). P/E Ratio (0.000) is within average values for comparable stocks, (36.230). GKOS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.720). GKOS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (12.019) is also within normal values, averaging (84.366).

View a ticker or compare two or three
GKOS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

GKOS is expected to report earnings to rise 28.25% to -20 cents per share on February 19

Glaukos Corp GKOS Stock Earnings Reports
Q4'25
Est.
$-0.21
Q3'25
Beat
by $0.10
Q2'25
Beat
by $0.02
Q1'25
Beat
by $0.13
Q4'24
Missed
by $0.02
The last earnings report on October 29 showed earnings per share of -15 cents, beating the estimate of -25 cents. With 1.29M shares outstanding, the current market capitalization sits at 5.72B.
A.I. Advisor
published General Information

General Information

an ophthalmic medical device company

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
One Glaukos Way
Phone
+1 949 367-9600
Employees
907
Web
https://www.glaukos.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DODGX17.050.30
+1.79%
Dodge & Cox Stock I
HEOVX17.840.28
+1.59%
Hartford Climate Opportunities R6
IENIX32.99N/A
N/A
Invesco Energy R5
FZACX40.62N/A
N/A
Fidelity Advisor Diversified Stock Z
NINLX23.07N/A
N/A
Neuberger Berman Intrinsic Value I

GKOS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GKOS has been loosely correlated with ISRG. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if GKOS jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GKOS
1D Price
Change %
GKOS100%
+4.64%
ISRG - GKOS
51%
Loosely correlated
+1.70%
NTRA - GKOS
48%
Loosely correlated
+2.25%
RDNT - GKOS
48%
Loosely correlated
+4.72%
TWST - GKOS
46%
Loosely correlated
+9.59%
ALGN - GKOS
43%
Loosely correlated
+7.34%
More

Groups containing GKOS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GKOS
1D Price
Change %
GKOS100%
+4.64%
Medical/Nursing Services
industry (216 stocks)
54%
Loosely correlated
+2.90%
Health Services
industry (423 stocks)
-3%
Poorly correlated
+2.35%